If you read the review of the Mercedes-Benz CLE 300 that my colleague Samuel Tremblay-Michaud wrote, it is easy to see that this is the basic version. It was expected that a version would be developed AMG, and that’s exactly what the manufacturer did. Today it launches the first AMG version of the CLE series, … [Read more…]
New report sheds light on why OpenAI’s board said Altman was ‘not consistently open’
Enlarge / Sam Altman, president of Y Combinator and co-chair of OpenAI, seen here in July 2016. Drew Angerer/Getty Images News When Sam Altman was suddenly removed as OpenAI’s CEO – before being reinstated days later – the company’s board publicly justified the move by saying that Altman “was not consistently open in his communications … [Read more…]
Have a Nice Death: This roguelike appears on XBOX and PLAYSTATION – ConsoleFun
PlayStation and Xbox players can rejoice because I wish you a happy death, the 2D roguelike from Gearbox Publishing and Magic Design Studios, is now available for €24.99 on PlayStation 5, PlayStation 4, Xbox Series X|S and Xbox One. Because good news never comes easy (and to reward fans’ patience), players can get it at … [Read more…]
JetBlue seeks court approval to acquire Spirit Airlines – The New York Times
Smaller airlines that operate in the shadows of the country’s four dominant carriers are feeling increasing pressure to merge with others to gain access to more planes and airport gates. That dynamic was highlighted in federal court in Boston on Tuesday as JetBlue Airways tried to convince a judge to let it buy Spirit Airlines … [Read more…]
Demon Slayer -Kimetsu no Yaiba- Sweep the board! Coming soon to Nintendo Switch – ConsoleFun
SEGA announces this Demon Slayer -Kimetsu no Yaiba- Sweep the board!produced by Aniplex, will be available for Nintendo Switch in America and Europe on April 26, 2024. In parallel with this announcement, two new game boards were revealed today: “Board Two,” depicting Tsuzumi Mansion and Mount Natagumo, and “Board Three,” featuring the Mugen Train. You’ll … [Read more…]
Traders made millions in anticipation of the October 7 Hamas attack, study says
Israeli regulators are examining a report alleging that investors made millions of dollars by short-selling Israeli stocks days before the Oct. 7 Hamas attack and appeared to have profited from anticipation of the bloody attack, several media outlets reported Tuesday. The unknown traders behind the activity placed bets against the value of a bundle of … [Read more…]
Stock Market News Today: Dow Lags as Job New Data Shows Slowing Labor Demand
Bank managers are “cautious” going into 2024 Bank executives expressed caution when speaking at Goldman Sachs’ U.S. financial services conference in Manhattan on Tuesday. As David Hollerith of Yahoo Finance reports: Executives at some of the nation’s largest banks pointed to the resilience of the U.S. economy but warned that loan losses are likely to … [Read more…]
The media is doing badly: A graphic to understand
CBC/Radio-Canada announced Monday it was laying off 600 employees in Canada, including several hundred in Quebec. Since the beginning of this year more than 1,200 jobs were cut in Quebec media. News Cuts should be announced soon. We’ve known it since Friday, but now it’s official: CBC/Radio-Canada will cut 600 jobs, or about 10% of … [Read more…]
U.S. job openings declined in October – The New York Times
Why it matters: The state of the labor market influences interest rate policy. The labor market is being closely watched by the Federal Reserve as it considers its interest rate policy. A cooling labor market tends to fuel forecasts that the Fed will not raise interest rates further, which have risen to a range of … [Read more…]
Eli Lilly’s obesity drug now available in US pharmacies
An Eli Lilly and Company pharmaceutical manufacturing facility is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Portal/Mike Segar/File Photo Acquire License Rights Dec 5 (Portal) – Eli Lilly (LLY.N) said on Tuesday that its recently approved obesity treatment, Zepbound, is now available in U.S. pharmacies and will cost $550 for … [Read more…]